publication venue for
- Effects of pravastatin in heart transplant recipients: implications of Kobashigawa et al.. 6. 1995
- The unique role of apolipoprotein A-I in HDL remodeling and metabolism.. 17. 2006
- Enhancing reverse cholesterol transport: the case for phosphatidylcholine therapy.. 16. 2005
- Reduction of coronary events: evidence from clinical trials.. 6. 1995
- Fatty liver and cerebrovascular disease: plausible association and possible mechanisms. 2022
- Lipids and peripheral neuropathy. 2021
- Metabolic and cardiovascular outcomes of bariatric surgery. 2020
- Regulation of lipid rafts, angiogenesis and inflammation by AIBP. 2019
- Pathophysiology of dyslipidemia and increased cardiovascular risk in HIV lipodystrophy: a model of 'systemic steatosis'. 2004
- Pleiotropic effects of statins: do they matter? 2001
- Hepatocellular transport and secretion of biliary lipids. 1999
- Effects of lipid lowering therapy on progression of coronary and carotid artery disease. 1997
- Current status of low density lipoprotein-apheresis for the therapy of severe hyperlipidemia. 1996
- Hypertension, dyslipidemia, and insulin resistance: links in a chain or spokes on a wheel? 1996
- Advances in LDL-apheresis for the treatment of severe hypercholesterolemia. 1994